Cargando…
Impact of Quantitative Assessment of Parkinson’s Disease-Associated Symptoms Using Wearable Technology on Treatment Decisions
Autores principales: | Carroll, Camille, Kobylecki, Christopher, Silverdale, Monty, Thomas, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700649/ https://www.ncbi.nlm.nih.gov/pubmed/31081794 http://dx.doi.org/10.3233/JPD-191623 |
Ejemplares similares
-
Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain Stimulation
por: Noui, Yassine, et al.
Publicado: (2021) -
Orofacial pain in 1916 patients with early or moderate Parkinson disease
por: O'Neill, Francis, et al.
Publicado: (2021) -
Genome‐Wide Association Study of Pain in Parkinson's Disease Implicates TRPM8 as a Risk Factor
por: Williams, Nigel M., et al.
Publicado: (2020) -
Generalized Dystonia Due to a Pathogenic THAP1 Variant Showing Sustained Response to Globus Pallidus Deep Brain Stimulation
por: Bhattacharjee, Shakya, et al.
Publicado: (2023) -
Increased Intraepidermal Nerve Fiber Degeneration and Impaired Regeneration Relate to Symptoms and Deficits in Parkinson's Disease
por: Jeziorska, Maria, et al.
Publicado: (2019)